A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
for Huntington Disease
Sites in Nashville, Memphis +32 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 21 - 70
Code: NCT07326709·Phase 3·Recruiting·Listed Jan 2026